Integra LifeSciences Holdings (IART)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 1,081,680 | 1,058,040 | 1,161,500 | 1,153,720 | 1,237,200 |
| Total current liabilities | US$ in thousands | 922,126 | 306,980 | 320,906 | 340,021 | 401,013 |
| Current ratio | 1.17 | 3.45 | 3.62 | 3.39 | 3.09 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $1,081,680K ÷ $922,126K
= 1.17
From the provided data, the current ratio of Integra LifeSciences Holdings has exhibited a generally increasing trend over the past five years. As of December 31, 2020, the current ratio stood at 3.09, indicating the company had $3.09 in current assets for every $1 in current liabilities. This ratio improved to 3.39 by the end of 2021, further increasing to 3.62 by the end of 2022, showing a strengthening liquidity position.
However, there was a slight decline in the current ratio in the following year, dropping to 3.45 by December 31, 2023. Notably, by the end of 2024, the current ratio experienced a significant decrease to 1.17, indicating a notable decrease in the company's liquidity position.
Overall, Integra LifeSciences Holdings has maintained a healthy current ratio above 1 over the years, suggesting the company has sufficient current assets to cover its short-term obligations. The fluctuation in the current ratio may be attributed to changes in the company's current assets and liabilities mix, signaling a need to monitor the trends carefully to ensure the company's liquidity remains stable.
Peer comparison
Dec 31, 2024